Entropy Technologies’s Bristol-Myers Squibb BMY Stock Holding History

Entropy Technologies’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-98,252	Closed	-$5.96M	–	973
2026 Q1	$5.96M	Sell	98,252 -164,892	-63%	-$9.61M	0.27%	105
2025 Q4	$14.2M	Buy	263,144 +119,453	+83%	+$5.75M	0.77%	23
2025 Q3	$6.48M	Buy	+143,691	New	+$6.71M	0.48%	42
2024 Q4	–	Sell	-110,022	Closed	-$5.69M	–	741
2024 Q3	$5.69M	Sell	110,022 -26,086	-19%	-$1.22M	0.6%	24
2024 Q2	$5.65M	Buy	+136,108	New	+$6.09M	0.61%	29
2024 Q1	–	Sell	-11,702	Closed	-$600K	–	724
2023 Q4	$600K	Buy	+11,702	New	+$614K	0.11%	304

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Entropy Technologies's BMY Position: Q2 2026 in Review

Entropy Technologies sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 98,252 shares — an estimated $5.96M sold.

Entropy Technologies first reported a position in BMY in Q4 2023 and held it in 6 quarters. The position peaked at $14.2M in Q4 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Entropy Technologies reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Entropy Technologies sold 98,252 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.96M.
Entropy Technologies first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 6 quarters.
Entropy Technologies's Bristol-Myers Squibb position peaked at $14.2M in Q4 2025.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.